TORONTO--(BUSINESS WIRE)--Bluma Wellness Inc. (the “Company” or “Bluma Wellness”) (CSE: BWEL.U) announces that it has changed its auditors from SRCO Professional Corporation (the “Former Auditor”) to Marcum LLP (the “Successor Auditor”) effective November 19, 2020. At the request of the Company, the Former Auditor resigned as the auditor of the Company effective November 19, 2020 and the board of directors of the Company appointed the Successor Auditor as the Company's auditor effective November 19, 2020, until the next Annual General Meeting of the Company.
"We would like to thank SRCO Professional Corporation for their services and guidance, and we are excited to work with Marcum and their experienced team as we continue to scale up our operations in Florida,” said Brady Cobb, Chief Executive Officer of Bluma Wellness.
In accordance with National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”), the notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the board of directors of the Company and will shortly be filed on SEDAR. There were no “reportable events” as such term is defined in NI 51-102 between the Company and the Former Auditor.
About Bluma Wellness Inc.
Bluma Wellness Inc. owns and operates a vertically-integrated, licensed medical cannabis company in the State of Florida doing business as “One Plant Florida.” One Plant Florida cultivates, processes, dispenses and retails medical cannabis to qualified patients in the State of Florida through multiple retail dispensaries and an innovative next-day door-to-door e-commerce home delivery service, thereby offering convenient access for its customers and meeting the demands of an evolving retail landscape. Bluma Wellness plans to continue expanding its cultivation and distribution operations as the Florida market grows and may enter into other US states where the production, distribution and use of cannabis is permitted under state law.
Additional Information
The Company’s securities have not been and will not be registered under the U.S. Securities Act and may not be offered or sold in the United States or to a U.S. Person absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.